The preoperative assessment begins with a comprehensive history and physical examination focused on identifying factors that influence anesthetic risk. Key elements include: cardiac history (ischemic heart disease, heart failure, valvular disease, arrhythmias, hypertension), pulmonary history (asthma, COPD, sleep apnea, smoking), renal and hepatic function, endocrine disorders (diabetes, thyroid, adrenal), bleeding disorders, previous anesthetic complications (malignant hyperthermia, difficult airway, PONV), allergies, and current medications including herbal supplements. The physical examination should include vital signs, cardiovascular and respiratory auscultation, airway assessment (Mallampati score, thyromental distance, interincisor gap, neck range of motion), and identification of potential intravenous access challenges.

The Mallampati classification is performed with the patient sitting upright, mouth fully open, and tongue protruding without phonation. Class I: soft palate, uvula, fauces, and pillars visible. Class II: soft palate and uvula visible. Class III: soft palate and base of uvula visible. Class IV: only hard palate visible. A higher Mallampati class (III or IV) predicts difficult mask ventilation and intubation. The thyromental distance is measured from the chin to the thyroid notch with the neck extended; a distance less than 6 cm suggests a difficult laryngoscopy. The interincisor gap (mouth opening) should be at least 3 fingerbreadths (approximately 5 cm) for adequate laryngoscopy. The upper lip bite test assesses mandibular protrusion: class I (lower incisors can bite upper lip above vermillion border), class II (can bite lower vermillion border), class III (cannot bite upper lip) predicts increasing difficulty. Neck circumference greater than 40 cm is associated with difficult laryngoscopy. A combined assessment using multiple predictive factors is more accurate than any single test.

Standard NPO guidelines to reduce pulmonary aspiration risk: clear liquids (water, black coffee, pulp-free juice, carbonated beverages) may be consumed up to 2 hours before elective procedures requiring general anesthesia, regional anesthesia, or procedural sedation. A light meal (tea and toast) is permitted up to 6 hours prior. A full meal (including fried or fatty foods, meat) requires at least 8 hours of fasting. For patients with delayed gastric emptying (diabetes, gastroparesis, obesity, pregnancy, opioid use), longer fasting intervals may be necessary. In emergency situations where the patient has a full stomach, rapid sequence induction and intubation (RSI) with cricoid pressure is indicated. Gastric ultrasound can be used to assess gastric content and volume when aspiration risk is uncertain. Preoperative administration of non-particulate antacids (30 mL of 0.3M sodium citrate), metoclopramide 10 mg IV, and H2 antagonists (ranitidine 50 mg IV) can reduce the risk of pneumonitis if aspiration occurs.

Basic airway management begins with proper patient positioning: the sniffing position (flexion of the lower cervical spine with extension of the atlanto-occipital joint) aligns the oral, pharyngeal, and laryngeal axes for optimal laryngoscopy. The jaw thrust maneuver displaces the mandible anteriorly, lifting the tongue and epiglottis off the posterior pharyngeal wall, and is the initial airway maneuver in suspected cervical spine injury. The head tilt-chin lift maneuver extends the neck and lifts the chin to open the airway in patients without suspected cervical trauma. Oropharyngeal airways (Guedel) are curved devices that maintain patency by preventing the tongue from falling back; they are sized by measuring from the corner of the mouth to the angle of the mandible or earlobe. Nasopharyngeal airways are softer and better tolerated in semi-conscious patients; they are sized by measuring from the naris to the tragus and lubricated before insertion through the most patent nostril.

Two-person bag-mask ventilation is superior to one-person technique and should be used when difficulty is anticipated. The two-person technique involves one operator using both hands to maintain a mask seal with jaw thrust while the second operator compresses the reservoir bag. Ventilation adequacy is assessed by chest rise, breath sounds, end-tidal CO2 detection, and oxygen saturation. Predictors of difficult mask ventilation (DMV) include: age over 55, BMI over 30, beard, Mallampati III or IV, limited jaw protrusion, history of snoring or OSA, and presence of teeth (edentulous patients actually have easier mask seal). The MOANS mnemonic summarizes DMV predictors: Mask seal, Obstruction/obesity, Age over 55, No teeth, Stiff lungs/snoring. If mask ventilation is impossible despite optimal positioning and adjuncts, proceed immediately to supraglottic airway placement or emergency surgical airway.

The laryngeal mask airway (LMA) is a supraglottic device that sits above the glottis, forming a seal around the laryngeal inlet. It is inserted blindly and provides a hands-free airway during spontaneous or controlled ventilation. The classic LMA is ideal for short procedures where tracheal intubation is not required. Newer generations include the ProSeal LMA (gastric access port, higher seal pressure), i-gel (non-inflatable cuff, gel-like seal), and LMA Supreme (gastric access, bite block). Contraindications to LMA use include: fasting non-compliance, morbid obesity, hiatal hernia with reflux, prolonged surgery, non-supine positioning, and patients requiring high airway pressures (over 20 cmH2O). Complications include aspiration, laryngospasm, airway obstruction from malposition, and gastric insufflation. The LMA is also a crucial rescue device in the difficult airway algorithm when mask ventilation and intubation are both impossible.

Direct laryngoscopy with a Macintosh (curved) or Miller (straight) blade is the standard technique for endotracheal intubation. The Macintosh blade is inserted into the vallecula and lifted to expose the glottis by elevating the hyoepiglottic ligament. The Miller blade is placed directly under the epiglottis to lift it. The Cormack-Lehane grading system describes laryngeal view: grade I (full view of glottis), grade IIa (partial view of glottis), grade IIb (only arytenoids or posterior commissure visible), grade III (only epiglottis visible), grade IV (no glottic structure visible). An ETT with stylet is passed through the vocal cords under direct vision. Confirmation of correct placement is by direct visualization through the cords, bilateral chest rise and breath sounds, absence of gastric insufflation, end-tidal CO2 detection (most reliable), and chest X-ray showing the tip 2-4 cm above the carina. The optimal depth for ETT insertion is typically 21-23 cm at the incisors for men and 20-22 cm for women. The tube cuff is inflated to a pressure of 20-30 cmH2O to provide an adequate seal while maintaining tracheal mucosal perfusion.

Video laryngoscopes (GlideScope, C-MAC, McGrath) incorporate a camera at the blade tip, providing an indirect view of the glottis on a screen. They improve glottic visualization compared to direct laryngoscopy, particularly in patients with difficult airways (Mallampati III-IV, limited cervical spine motion, obesity). The learning curve is shorter than direct laryngoscopy, and they are now recommended as the first-line device for predicted difficult intubation by many guidelines. The flexible fiberoptic bronchoscope is the gold standard for awake intubation in the anticipated difficult airway. The patient is topically anesthetized with lidocaine and the scope is passed orally or nasally to visualize the glottis, then the ETT is railroaded over the scope. The Airtraq optical laryngoscope is a single-use device with a blade that provides a magnified view without requiring alignment of oral-pharyngeal-laryngeal axes. The King LT and Combitube are supraglottic devices used primarily in emergency and prehospital settings for difficult airways.

The ASA Difficult Airway Algorithm provides a structured approach to the unanticipated difficult airway. It begins with an airway assessment to formulate a primary plan (usually intubation). If intubation fails, the algorithm branches based on whether mask ventilation is adequate. If both intubation and mask ventilation fail (can't intubate, can't ventilate = CICO), an emergency surgical airway is indicated. The approach follows: call for help, optimize positioning, attempt supraglottic device (LMA), attempt video laryngoscopy, and if still unable to ventilate, perform cricothyrotomy or tracheostomy. The surgical cricothyrotomy involves a vertical skin incision over the cricothyroid membrane followed by horizontal incision through the membrane and insertion of a 4-6 mm endotracheal or tracheostomy tube. Needle cricothyrotomy with jet ventilation is a temporary measure. The Difficult Airway Society (DAS) guidelines emphasize the importance of planning, limiting attempts to 3-4 by an experienced operator, and early conversion to an emergency surgical airway.

Propofol is the most commonly used induction agent due to its rapid onset (30-45 seconds), smooth induction, and rapid clearance. The induction dose is 1-2.5 mg/kg IV, with lower doses in the elderly and hypovolemic patients. Side effects include hypotension (from vasodilation and myocardial depression), pain on injection, apnea, and dose-dependent respiratory depression. Propofol has potent antiemetic properties and is the agent of choice for TIVA (total intravenous anesthesia). Thiopental (a barbiturate) produces rapid induction in 10-30 seconds with dose of 3-5 mg/kg; it causes myocardial depression, peripheral vasodilation, and histamine release. Etomidate is the induction agent of choice for hemodynamically unstable patients due to its cardiovascular stability; the dose is 0.2-0.3 mg/kg. Its major drawback is adrenal suppression (even after a single dose) and myoclonus on induction. Ketamine produces dissociative anesthesia with profound analgesia and cardiovascular stimulation (increased heart rate, blood pressure, and cardiac output). Induction dose is 1-2 mg/kg IV or 4-5 mg/kg IM. Contraindicated in patients with elevated intracranial pressure, severe hypertension, and psychiatric disorders due to emergence delirium.

Sevoflurane is the preferred inhalational induction agent due to its non-pungent odor and low blood-gas partition coefficient (0.65), allowing rapid induction and emergence. It is commonly used for inhalation induction in pediatric patients and adults with difficult IV access. Sevoflurane can produce nephrotoxic Compound A in low-flow circuits with CO2 absorbents containing strong bases. Desflurane has the lowest blood-gas partition coefficient (0.42), providing the fastest emergence of all volatile agents. It is pungent and irritating to airways, making it unsuitable for inhalation induction. It is best used for maintenance, particularly in obese patients. Isoflurane has intermediate properties with a blood-gas partition coefficient of 1.4 and slower onset than sevoflurane or desflurane. It is a potent coronary vasodilator. Halothane, now rarely used, is associated with halothane hepatitis (1 in 10,000 to 35,000 exposures), particularly in adult females. All volatile anesthetics potentiate the effects of neuromuscular blocking agents, cause dose-dependent respiratory depression, and undergo minimal hepatic metabolism (less than 5%). The MAC (minimum alveolar concentration) is the concentration at which 50% of patients do not move to a surgical incision. MAC values are additive and decreased by opioids, sedatives, hypothermia, and increased age.

Opioids are integral to balanced anesthesia. Fentanyl is a synthetic opioid 100 times more potent than morphine, with rapid onset (1-2 minutes) and short duration (20-30 minutes). The typical induction dose is 1-3 mcg/kg. Remifentanil is an ultra-short-acting opioid metabolized by plasma esterases, with a context-sensitive half-life of 3-4 minutes regardless of infusion duration. It provides profound intraoperative analgesia and allows rapid emergence. Its major limitation is postoperative pain requiring early transition to longer-acting analgesics. Morphine has a slower onset (5-10 minutes) and longer duration (2-4 hours), making it suitable for postoperative analgesia. Benzodiazepines (midazolam 0.02-0.05 mg/kg) provide anxiolysis, antegrade amnesia, and synergize with other anesthetic agents. Midazolam is the most commonly used preoperative sedative. TIVA typically uses propofol (50-200 mcg/kg/min) combined with remifentanil (0.05-2 mcg/kg/min) via target-controlled infusion (TCI) or manual infusion. Advantages of TIVA include: reduced PONV, decreased emergence coughing, avoidance of malignant hyperthermia triggers, and consistent delivery in patients with difficult airways.

Standard monitoring during general anesthesia includes: continuous ECG, non-invasive blood pressure (NIBP) at least every 5 minutes, pulse oximetry (SpO2), capnography (end-tidal CO2), temperature, and inspired/expired anesthetic gas concentrations. The bispectral index (BIS) monitors processed EEG to assess depth of anesthesia on a scale from 0 (isoelectric EEG) to 100 (awake). The target BIS range for general anesthesia is 40-60. BIS monitoring reduces the risk of intraoperative awareness (which occurs in 1-2 per 1000 cases under general anesthesia) and can reduce anesthetic consumption. Entropy monitoring and evoked potentials are alternative depth-of-anesthesia modalities. The isolated forearm technique can detect responsiveness during anesthesia but is not routinely used. Heart rate variability and surgical pleth index provide nociception monitoring. A multimodal monitoring approach incorporating processed EEG, hemodynamic responses, and clinical signs (tearing, sweating, movement) provides the most comprehensive assessment.

Emergence from anesthesia begins when volatile agents are discontinued and the patient regains consciousness. Criteria for extubation include: spontaneous ventilation with adequate tidal volume and respiratory rate, ability to follow commands, intact airway reflexes (gag, cough), hemodynamic stability, normothermia, and adequate neuromuscular reversal (train-of-four ratio over 0.9). Deep extubation (extubation while still anesthetized) may be used in patients with reactive airways or to avoid coughing and straining, but requires careful patient selection and airway assessment. The patient is transferred to the post-anesthesia care unit (PACU) with supplemental oxygen, pulse oximetry, and appropriate monitoring. Common PACU complications include: hypoxemia (most common), hypotension or hypertension, arrhythmias, postoperative nausea and vomiting (PONV), shivering, emergence delirium, pain, and airway obstruction. The Aldrete scoring system (activity, respiration, circulation, consciousness, oxygen saturation, each scored 0-2) determines readiness for discharge from the PACU.

Spinal anesthesia involves injection of local anesthetic into the subarachnoid space (cerebrospinal fluid), typically at the L2-L3, L3-L4, or L4-L5 interspace (below the termination of the spinal cord at L1-L2 in adults). The block produces rapid onset (1-5 minutes) of dense sensory and motor blockade. The level of blockade depends on baricity (hyperbaric bupivacaine 0.5% with dextrose spreads caudally with gravity), patient positioning, dose, and volume. Common local anesthetics: bupivacaine (longest duration, most cardiotoxic), lidocaine (short duration, risk of transient neurologic symptoms), and ropivacaine (less cardiotoxic). Opioids (morphine, fentanyl) are often added to prolong analgesia. Indications include lower abdominal, pelvic, perineal, and lower extremity surgery. Contraindications include patient refusal, coagulopathy (INR over 1.4, platelets under 50-100,000), infection at puncture site, increased intracranial pressure, severe hypovolemia, and severe aortic stenosis. Complications include post-dural puncture headache (PDPH), hypotension (from sympathectomy), bradycardia, high spinal, total spinal, back pain, and rarely spinal hematoma or abscess.

Epidural anesthesia involves injection of local anesthetic into the epidural space (outside the dura), typically at lumbar or thoracic levels. The onset is slower than spinal (10-20 minutes), the block is less dense, and the dose required is 8-10 times higher. The epidural space is identified by loss of resistance to saline or air as the needle passes through the ligamentum flavum. A test dose (3 mL of 1.5% lidocaine with 1:200,000 epinephrine) is administered to exclude intravascular or subarachnoid placement. Continuous epidural infusion (local anesthetic with opioid) provides excellent postoperative analgesia. Combined spinal-epidural (CSE) offers rapid onset of spinal with the flexibility of continuous epidural for labor and postoperative analgesia. Indications include labor analgesia, postoperative pain management (thoracic epidurals for abdominal and thoracic surgery), and as the primary anesthetic for lower extremity and abdominal surgeries. Contraindications are similar to spinal. Complications include accidental dural puncture (wet tap with PDPH), incomplete block, intravascular injection (seizures, cardiac arrest), subarachnoid injection (high spinal), epidural hematoma, and epidural abscess.

Ultrasound guidance has revolutionized peripheral nerve blockade, allowing real-time visualization of nerves, needle tip, and local anesthetic spread. Upper extremity blocks include: interscalene block (shoulder and proximal humerus), supraclavicular block (entire upper extremity, dense and rapid), infraclavicular block (arm and forearm), and axillary block (forearm and hand). Lower extremity blocks include: femoral nerve block (anterior thigh, femur, knee), sciatic nerve block (posterior thigh, lower leg, foot), adductor canal block (postoperative knee analgesia), popliteal block (foot and ankle), and lumbar plexus block (hip and proximal femur). Truncal blocks include: transversus abdominis plane (TAP) block (abdominal wall analgesia), rectus sheath block (midline incisions), paravertebral block (unilateral thoracic and abdominal analgesia), and erector spinae plane (ESP) block. Complications include nerve injury (1:1000 to 1:5000), local anesthetic systemic toxicity (LAST), hematoma, infection, and phrenic nerve palsy (interscalene block).

Local anesthetics are classified as amides or esters based on the linkage between the aromatic ring and the tertiary amine. Amides include lidocaine, bupivacaine, ropivacaine, mepivacaine, and prilocaine. Esters include procaine, chloroprocaine, tetracaine, and cocaine. The mechanism of action is blockade of voltage-gated sodium channels on nerve cell membranes, preventing depolarization and propagation of action potentials. Lidocaine binds to the inactivated state of the sodium channel with rapid onset (2-5 minutes) and intermediate duration (60-120 minutes). Bupivacaine has slower onset (5-10 minutes) but prolonged duration (120-240 minutes) due to higher protein binding (95%) and pKa (8.1). Ropivacaine is similar to bupivacaine but with less cardiotoxicity and motor blockade, making it ideal for epidural infusion and peripheral nerve blocks. Chloroprocaine has the fastest onset (1-3 minutes) and shortest duration (30-60 minutes) due to rapid metabolism by plasma pseudocholinesterases.

Maximum safe doses: lidocaine with epinephrine 7 mg/kg (plain lidocaine 4.5 mg/kg), bupivacaine 3 mg/kg (with or without epinephrine), ropivacaine 3 mg/kg, mepivacaine 7 mg/kg, and prilocaine 8 mg/kg. Epinephrine (1:100,000 to 1:200,000 concentration, equivalent to 5-10 mcg/mL) is added to local anesthetics to cause vasoconstriction, which reduces systemic absorption, prolongs block duration, and decreases peak plasma concentration. Epinephrine is contraindicated in end-artery areas (digits, penis, ears, nose) due to risk of ischemic necrosis. It should be used with caution in patients with severe hypertension, tachyarrhythmias, and hyperthyroidism. The addition of sodium bicarbonate (1 mEq per 10 mL of 1% lidocaine) alkalinizes the solution, increasing the non-ionized fraction and reducing pain on injection while speeding onset. Bupivacaine should not be mixed with bicarbonate as it may precipitate.

LAST is a life-threatening complication resulting from inadvertent intravascular injection or excessive dosing. Early CNS symptoms include perioral numbness, metallic taste, tinnitus, dizziness, and visual disturbances. Progressive toxicity causes slurred speech, muscle twitching, seizures, and ultimately unconsciousness. Cardiovascular toxicity follows CNS toxicity with bupivacaine, but can occur simultaneously or first with lidocaine. Cardiac effects include myocardial depression, arrhythmias (wide QRS, VT, VF), and cardiac arrest. Bupivacaine is particularly cardiotoxic due to its high affinity for cardiac sodium channels (slow off-rate), making resuscitation difficult. Treatment of LAST: stop the injection, call for help, airway management with 100% oxygen, benzodiazepines for seizures (avoid propofol in hemodynamically unstable patients), and immediate administration of 20% lipid emulsion (Intralipid) 1.5 mL/kg bolus over 1 minute followed by infusion at 0.25 mL/kg/min for 30 minutes. Cardiopulmonary resuscitation with prolonged effort is necessary as local anesthetic binding to cardiac channels may take 30-60 minutes to resolve. Avoid vasopressin, calcium channel blockers, and lidocaine in LAST resuscitation.

Succinylcholine is the only depolarizing neuromuscular blocker in clinical use. It binds to the nicotinic acetylcholine receptor at the neuromuscular junction, causing initial depolarization (fasciculations) followed by prolonged depolarization and receptor desensitization (paralysis). Onset is rapid (30-60 seconds) with duration of 4-6 minutes. The standard intubating dose is 1-1.5 mg/kg IV. Succinylcholine is metabolized by plasma pseudocholinesterase (butyrylcholinesterase). Patients with atypical pseudocholinesterase experience prolonged paralysis. Side effects include: hyperkalemia (particularly in patients with burns, denervation, immobilization, crush injury, muscular dystrophy, or stroke), malignant hyperthermia trigger, bradycardia (especially with repeat doses), increased intraocular, intragastric, and intracranial pressure, masseter spasm, and myalgia from fasciculations. Defasciculating doses of a nondepolarizing NMBD (rocuronium 0.03 mg/kg) can be given 3 minutes before succinylcholine to reduce fasciculations and myalgia.

Nondepolarizing NMBDs competitively block acetylcholine at the nicotinic receptor, preventing depolarization. They are classified by chemical structure: aminosteroids (rocuronium, vecuronium, pancuronium) and benzylisoquinolines (cisatracurium, atracurium, mivacurium). Rocuronium is the most commonly used due to its rapid onset (60-90 seconds at 0.6-1.2 mg/kg) and intermediate duration (30-60 minutes). It can be used for rapid sequence intubation at doses of 1-1.2 mg/kg when succinylcholine is contraindicated. Vecuronium has intermediate duration (30-45 minutes) with minimal hemodynamic effects. Cisatracurium undergoes organ-independent Hofmann elimination, making it ideal for patients with hepatic or renal impairment. Pancuronium is a long-acting agent (60-120 minutes) that causes vagolytic tachycardia. Atracurium undergoes Hofmann elimination and ester hydrolysis, producing laudanosine (which can cause seizures in high concentrations). Reversal of nondepolarizing blockade is achieved with acetylcholinesterase inhibitors (neostigmine 0.04-0.07 mg/kg with glycopyrrolate 0.01 mg/kg to block muscarinic side effects) or sugammadex, a selective relaxant-binding agent that encapsulates rocuronium or vecuronium.

Neuromuscular monitoring uses peripheral nerve stimulators, most commonly the train-of-four (TOF) pattern (four supramaximal stimuli at 2 Hz). The TOF ratio (T4/T1) is the gold standard for assessing recovery. Adequate recovery is defined as a TOF ratio of 0.9 or greater. The adductor pollicis muscle (ulnar nerve stimulation) is the standard monitoring site. Other patterns include: double-burst stimulation (DBS, more sensitive than TOF for tactile assessment), tetanic stimulation (50 or 100 Hz for 5 seconds), and post-tetanic count (PTC, for deep block assessment). Sugammadex has revolutionized reversal of rocuronium and vecuronium blockade. The dose depends on depth of block: 2 mg/kg for moderate block (TOF ratio 0.2-0.5), 4 mg/kg for deep block (PTC 1-2), and 16 mg/kg for immediate reversal following 1.2 mg/kg rocuronium. Sugammadex is superior to neostigmine as it provides more rapid, complete reversal regardless of the depth of block, causes no muscarinic side effects, and does not require co-administration of an anticholinergic. It is contraindicated in patients with severe renal impairment (creatinine clearance under 30 mL/min).

Crystalloids are the most commonly used intravenous fluids. Normal saline (0.9% NaCl) contains 154 mEq/L each of sodium and chloride. Large-volume administration can cause hyperchloremic metabolic acidosis due to the high chloride content. Lactated Ringer's solution contains 130 mEq/L sodium, 109 mEq/L chloride, 28 mEq/L lactate (bicarbonate precursor), 4 mEq/L potassium, and 3 mEq/L calcium. It is more physiologically balanced than normal saline, with less risk of hyperchloremia. Lactated Ringer's is contraindicated in patients with hepatic failure (cannot metabolize lactate) and should not be co-administered with blood products (calcium chelates citrate in stored blood). Plasmalyte is another balanced solution similar in composition to plasma. Colloids include albumin 5% and 25%, hydroxyethyl starches (HES), and gelatins. Albumin is used for volume expansion in specific situations (large-volume paracentesis, spontaneous bacterial peritonitis). HES solutions have fallen out of favor due to increased risk of acute kidney injury and bleeding in critically ill patients when compared to crystalloids.

The traditional approach divides perioperative fluid into: maintenance (replacing insensible losses and urine output, approximately 1-2 mL/kg/hr), deficit (replacing NPO deficit), and replacement (blood loss, third spacing). The 4-2-1 rule calculates maintenance: 4 mL/kg/hr for first 10 kg, 2 mL/kg/hr for next 10 kg, and 1 mL/kg/hr for each additional kg above 20 kg. Goal-directed fluid therapy (GDFT) uses dynamic parameters to individualize fluid administration: stroke volume variation (SVV), pulse pressure variation (PPV), and pleth variability index (PVI). SVV and PPV of 10-13% or higher suggest fluid responsiveness. GDFT guided by esophageal Doppler, arterial waveform analysis, or bioreactance reduces postoperative complications in high-risk surgery. Restrictive fluid strategies (1-2 L total for major abdominal surgery) have been associated with improved outcomes compared to liberal strategies (3-5 L). The ideal approach may be a balanced, goal-directed strategy avoiding both hypovolemia and fluid overload.

The decision to transfuse packed red blood cells is based on both hemoglobin concentration and clinical context. Restrictive transfusion triggers (hemoglobin less than 7-8 g/dL) are recommended for most patients, while higher thresholds (less than 9-10 g/dL) may be appropriate for patients with acute coronary syndrome, ongoing bleeding, or hemodynamic instability. Cross-matched blood is ideal. Type-specific (ABO and Rh) non-cross-matched blood can be used in emergencies. O-negative blood is the universal donor and is used in emergent situations when type is unknown. Massive transfusion protocol (MTP) is activated when a patient requires 10 or more units of PRBCs in 24 hours, or when exsanguination is imminent. An MTP typically delivers PRBCs, FFP, and platelets in a 1:1:1 ratio to approximate whole blood. Adjuncts in MTP include tranexamic acid (TXA) 1 g IV over 10 minutes followed by 1 g over 8 hours, calcium replacement (citrate chelation), and point-of-care viscoelastic testing (TEG, ROTEM) to guide component therapy.

Multimodal analgesia combines agents with different mechanisms to achieve superior pain control with reduced side effects and opioid consumption. Acetaminophen (paracetamol) 1 g IV q6h is a cornerstone of multimodal analgesia; it inhibits central prostaglandin synthesis and has an excellent safety profile. NSAIDs (ketorolac 15-30 mg IV q6h, ibuprofen 400-800 mg PO q6h, celecoxib 200 mg PO q12h) inhibit cyclooxygenase, reducing peripheral and central prostaglandin production. They reduce opioid consumption by 20-40% but are relatively contraindicated in patients with renal impairment, bleeding risk, gastrointestinal ulcers, and a history of coronary artery bypass grafting (CABG). Gabapentinoids (gabapentin 300-600 mg, pregabalin 75-150 mg) are given preoperatively to reduce neuropathic pain and opioid consumption. Alpha-2 agonists (clonidine, dexmedetomidine) provide sedation and analgesia with opioid-sparing effects. Dexmedetomidine is particularly useful for sedation without respiratory depression. Ketamine at subanesthetic doses (0.1-0.5 mg/kg bolus followed by 0.1-0.5 mg/kg/hr infusion) provides NMDA receptor antagonism, reducing central sensitization, opioid tolerance, and hyperalgesia.

Opioids remain the mainstay for moderate to severe acute postoperative pain. Morphine is the standard comparison opioid with an IV dose of 2-5 mg q2-4h. It undergoes hepatic metabolism to morphine-6-glucuronide (M6G, active and more potent) and morphine-3-glucuronide (M3G, neuroexcitatory). M6G accumulates in renal failure, increasing the risk of respiratory depression. Hydromorphone (0.2-0.5 mg IV) is 5-7 times more potent than morphine with fewer side effects and less histamine release. Fentanyl is 100 times more potent than morphine with rapid onset (60 seconds) and short duration (30-60 minutes); ideal for patient-controlled analgesia (PCA) and intraoperative use. Oxycodone is available orally and intravenously with bioavailability of 60-87% orally. Patient-controlled analgesia (PCA) allows patients to self-administer small bolus doses as needed. Typical morphine PCA settings: bolus 1-2 mg, lockout 5-10 minutes, basal rate generally avoided due to increased respiratory depression risk. Common opioid side effects include: respiratory depression, nausea and vomiting, constipation, urinary retention, pruritus, and sedation. Naloxone 0.04-0.08 mg IV titrated is the reversal agent for respiratory depression.

Epidural analgesia provides superior pain control for major thoracic, abdominal, and lower extremity surgery. A typical epidural infusion uses bupivacaine 0.0625-0.125% with fentanyl 2-5 mcg/mL or hydromorphone 10-50 mcg/mL at 4-10 mL/hr. Paravertebral blocks provide unilateral somatic and sympathetic blockade and are particularly effective for thoracotomy, breast surgery, and cholecystectomy. Transversus abdominis plane (TAP) blocks provide analgesia to the anterior abdominal wall and are used for laparotomy, laparoscopic surgery, and cesarean section. Erector spinae plane (ESP) blocks are a newer interfacial plane block providing thoracic and abdominal analgesia with a favorable safety profile. Continuous peripheral nerve blocks (interscalene, femoral, sciatic, adductor canal) using catheter techniques can provide days of postoperative analgesia. The addition of dexamethasone 4-8 mg or dexmedetomidine 0.5-1 mcg/kg to perineural local anesthetic extends block duration by 4-8 hours.

Pregnancy induces significant physiologic changes that impact anesthetic management. Cardiovascular: blood volume increases by 30-50%, heart rate increases by 15-20 bpm, and cardiac output increases by 30-50% at term. Aortocaval compression occurs in the supine position after 20 weeks gestation as the gravid uterus compresses the aorta and inferior vena cava, reducing cardiac output by up to 25-30%. This is managed by left uterine displacement (LUD) using a wedge under the right hip. Respiratory: functional residual capacity (FRC) decreases by 20% while oxygen consumption increases by 20-30%, resulting in rapid desaturation during apnea. Minute ventilation increases by 50%, with a compensatory respiratory alkalosis. Airway: mucosal edema and vascular engorgement in the upper airway make intubation more difficult, with a 1:250 incidence of failed intubation in obstetrics compared to 1:2000 in the general surgical population. Gastrointestinal: delayed gastric emptying, reduced lower esophageal sphincter tone, and increased intra-abdominal pressure increase the risk of aspiration (full stomach). Central neuraxial: engorged epidural veins reduce the volume of local anesthetic required for spinal and epidural anesthesia by 25-30% at term.

Epidural analgesia is the gold standard for labor pain. It is typically initiated when the patient is in active labor and requests pain relief, regardless of cervical dilation. Neuraxial analgesia does not increase the rate of cesarean delivery. A combined spinal-epidural (CSE) technique provides rapid onset of analgesia (within 2-5 minutes) with the flexibility of a continuous epidural. The spinal component typically uses fentanyl 15-25 mcg with or without bupivacaine 2.5 mg. The epidural infusion is maintained with low-concentration local anesthetic (bupivacaine 0.0625-0.125% with fentanyl 2 mcg/mL) at 6-12 mL/hr. Patient-controlled epidural analgesia (PCEA) allows the patient to self-administer boluses and reduces total anesthetic consumption. Alternative labor analgesia includes: nitrous oxide (50% N2O in O2), remifentanil PCA (considered when neuraxial is contraindicated but requires strict monitoring due to respiratory depression risk), and non-pharmacologic methods.

Neuraxial anesthesia is the preferred technique for elective and most emergency cesarean sections, with spinal anesthesia being the most common approach. A hyperbaric bupivacaine dose of 10-15 mg with fentanyl 10-25 mcg and morphine 100-200 mcg provides surgical anesthesia for 60-90 minutes with postoperative analgesia for 12-24 hours. The block should extend to T4 level to cover the surgical field. Hypotension occurs in 50-80% of spinal anesthetics for cesarean section despite left uterine displacement and IV fluid preloading. Management includes: phenylephrine 50-100 mcg IV bolus or infusion (preferred over ephedrine as it causes less fetal acidosis), or ephedrine 5-10 mg IV. General anesthesia for cesarean section is reserved for emergencies where neuraxial is contraindicated or there is insufficient time. Rapid sequence induction (RSI) with propofol 2 mg/kg or ketamine 1-2 mg/kg and succinylcholine 1-1.5 mg/kg is used. Thiopental was the traditional induction agent but propofol is now more commonly used. Ketamine is preferred in hemorrhagic shock. A short acting opioid (remifentanil 1 mcg/kg) at induction blunts the pressor response to intubation and protects the fetus from stress.

Postpartum hemorrhage is the leading cause of maternal mortality worldwide, most commonly caused by uterine atony. Management follows the 4 T's: Tone (uterine atony, most common: fundal massage, oxytocin 10-40 U per 1 L NS infusion, methergine 0.2 mg IM, carboprost 250 mcg IM q15min, misoprostol 600-1000 mcg PR/SL), Trauma (lacerations, uterine rupture), Tissue (retained placenta), and Thrombin (coagulopathy). Massive transfusion protocols should be activated early. Preeclampsia is a multisystem disorder defined by hypertension and proteinuria after 20 weeks gestation. Severe preeclampsia requires delivery and careful anesthetic planning. Magnesium sulfate 4-6 g IV load followed by 1-2 g/hr infusion is used for seizure prophylaxis and treatment of eclampsia. Magnesium potentiates neuromuscular blockers, so doses should be reduced. Regional anesthesia is safe in preeclampsia unless coagulopathy or severe thrombocytopenia (platelets under 50-70,000) is present. General anesthesia may be required but the hypertensive response to laryngoscopy can be blunted with remifentanil, esmolol, or hydralazine.

Children are not small adults and have distinct physiologic and pharmacologic differences from adult patients. The infant airway differs significantly: the larynx is higher (C3-C4 versus C6 in adults), the epiglottis is long and floppy (omega-shaped), the narrowest point is at the level of the cricoid cartilage (not the glottis as in adults), and the trachea is short. These differences explain the higher incidence of airway complications and the utility of straight blades (Miller) for intubation in infants. Oxygen consumption is 2-3 times higher in neonates (6-8 mL/kg/min versus 3-4 mL/kg/min in adults), leading to rapid desaturation during apnea. Functional residual capacity (FRC) is relatively lower and closing capacity is higher, predisposing infants to atelectasis and hypoxemia. Cardiovascular: neonates have a higher heart rate (120-160 bpm), lower systemic vascular resistance, and a leftward shift of the ventricular function curve; cardiac output is more heart-rate-dependent due to limited myocardial compliance. Drug dosing: higher volume of distribution for water-soluble drugs, reduced hepatic metabolism in neonates, and increased MAC for volatile anesthetics (peak at 1-6 months of age).

Inhalation induction with sevoflurane is the standard technique for pediatric patients, especially those without IV access. Sevoflurane is started at 2-3% in 100% oxygen and increased gradually to 6-8% as tolerated. A combination of sevoflurane with nitrous oxide 50-70% speeds induction. Intravenous induction is preferred in older children and when IV access is established. Propofol 2-3 mg/kg or ketamine 1-2 mg/kg are common choices. EMLA cream (lidocaine-prilocaine) applied 45-60 minutes before IV placement reduces the pain of venipuncture. Airway equipment selection: uncuffed endotracheal tubes are traditionally used in children under 8 years, though cuffed tubes are increasingly used at all ages when properly sized (the Cole formula: ETT size = age/4 + 4 for cuffed tubes). The optimal ETT depth at the lips is calculated as: age/2 + 12 cm for oral intubation. LMA sizes range from 1 (neonates up to 5 kg) to 5 (large adults). Most pediatric patients can be safely extubated awake when they are fully awake and following commands in older children, or deep to avoid coughing and laryngospasm in infants.

Neonates and infants are at higher risk of hypoglycemia due to limited glycogen stores, so blood glucose should be monitored and maintenance fluids should include dextrose (D5 1/2 NS or D5 LR) for neonates and infants. The 4-2-1 rule applies for maintenance fluids as with adults. Dextrose-containing maintenance fluids should be continued intraoperatively with blood glucose monitoring, particularly in prolonged procedures. Blood loss is poorly tolerated in neonates due to limited physiologic reserve; transfusion should be considered for losses exceeding 10% of blood volume (estimated blood volume: neonate 80-90 mL/kg, infant 70-80 mL/kg, older child 65-70 mL/kg). Hypothermia is a significant risk in pediatric patients due to a larger body surface area to weight ratio. Active warming measures are essential: forced air warming, warmed IV fluids, warmed humidified gases, and maintaining a warm ambient temperature.

Indications for mechanical ventilation include: failure of oxygenation (PaO2 under 60 mmHg on FiO2 over 0.6), failure of ventilation (PaCO2 over 50 mmHg with pH under 7.25), airway protection (GCS under 8), and anticipated clinical deterioration. Modes of ventilation include: volume-controlled (VCV, set tidal volume, variable airway pressure), pressure-controlled (PCV, set inspiratory pressure, variable tidal volume), pressure support (PSV, patient-triggered, pressure-limited), and synchronized intermittent mandatory ventilation (SIMV, mandatory breaths at set rate plus spontaneous breaths). Lung-protective ventilation for ARDS uses low tidal volumes (6 mL/kg of predicted body weight), plateau pressure less than 30 cmH2O, and adequate PEEP to prevent atelectotrauma. Permissive hypercapnia (PaCO2 up to 60-80 mmHg) is accepted to maintain low tidal volume ventilation. Driving pressure (plateau pressure minus PEEP) of 15 cmH2O or higher is associated with increased mortality. Prone positioning in ARDS with PaO2/FiO2 ratio under 150 improves oxygenation and reduces mortality. Neuromuscular blockade (cisatracurium infusion for 48 hours) may improve outcomes in severe ARDS.

Arterial lines provide continuous blood pressure monitoring and access for arterial blood gas sampling. The radial artery is the most common site; the Allen test should be performed before cannulation to confirm collateral circulation. Central venous catheters (CVC) are placed in the internal jugular, subclavian, or femoral veins for monitoring central venous pressure (CVP), administering vasoactive medications, and providing large-volume resuscitation. CVP is an unreliable predictor of fluid responsiveness. Dynamic measures of fluid responsiveness (SVV, PPV, passive leg raise) are more accurate. Vasopressors: norepinephrine is the first-line vasopressor for septic shock (dose 0.01-3 mcg/kg/min). Vasopressin 0.03 U/min can be added as a second agent. Epinephrine is used for anaphylactic shock and refractory hypotension. Dobutamine (2-20 mcg/kg/min) is the first-line inotrope for cardiogenic shock with low cardiac output. Milrinone (0.375-0.75 mcg/kg/min) is a phosphodiesterase-3 inhibitor with inotropic and vasodilator properties, useful in right heart failure. In refractory shock, consider corticosteroids (hydrocortisone 200 mg/day in divided doses or infusion).

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, identified by an acute change in SOFA score of 2 or more points. Septic shock is sepsis with vasopressor requirement to maintain MAP of 65 mmHg or higher and serum lactate over 2 mmol/L despite adequate volume resuscitation. The Surviving Sepsis Campaign guidelines emphasize the 1-hour bundle: measure lactate level, obtain blood cultures before antibiotics, administer broad-spectrum antibiotics, begin rapid crystalloid infusion (30 mL/kg), and start vasopressors if hypotensive during or after fluid resuscitation. Source control is essential (drainage of abscess, removal of infected lines, debridement of necrotic tissue). Lactate clearance (reduction by 20% or more in 6 hours) is a useful marker of resuscitation adequacy. Stress-dose steroids (hydrocortisone 200 mg/day) should be considered in patients with septic shock refractory to adequate fluid resuscitation and vasopressors.

Analgosedation is the preferred approach in the ICU: analgesia is provided first, followed by sedation as needed. The Richmond Agitation-Sedation Scale (RASS) is the most commonly used sedation assessment tool, ranging from +4 (combative) to -5 (unarousable). The target RASS should be individualized: -2 to 0 for most patients, deeper sedation (-3 to -4) for patients with severe ARDS or elevated intracranial pressure. Propofol and dexmedetomidine are preferred over benzodiazepines as they are associated with shorter ICU length of stay and less delirium. Daily sedation interruption (DSI, also called sedation vacation) involves temporarily stopping sedative infusions to assess neurologic status and reduce cumulative sedation. Delirium is an acute, fluctuating disturbance in attention and awareness. The Confusion Assessment Method for the ICU (CAM-ICU) is the validated screening tool. Prevention includes early mobilization, sleep protocols, minimizing deliriogenic medications (benzodiazepines, anticholinergics), and maintaining sensory orientation. Haloperidol is used for acute agitation but does not reduce delirium duration or mortality. Dexmedetomidine may reduce delirium duration in mechanically ventilated patients.

Rapid Sequence Induction (RSI) is the technique of choice when a patient has a full stomach and is at high risk of pulmonary aspiration. The classic RSI involves: preoxygenation with 100% oxygen for 3-5 minutes (or 8 vital capacity breaths over 60 seconds), administration of a predetermined induction agent and rapidly acting neuromuscular blocker in rapid succession, cricoid pressure (Sellick maneuver, 30-40 N of force) applied immediately after loss of consciousness until ETT placement is confirmed, and no positive pressure ventilation until the ETT cuff is inflated. Modern RSI has modified these principles: gentle mask ventilation with low pressures (10-15 cmH2O) is often used to prevent hypoxia, particularly in patients with low functional residual capacity (obesity, pregnancy, sepsis). Induction agents for RSI: ketamine 1-2 mg/kg is preferred in hemodynamically unstable patients; propofol 1.5-2 mg/kg is used in hemodynamically stable patients. Succinylcholine 1-1.5 mg/kg provides the fastest onset (30-60 seconds) and shortest duration. Rocuronium 1.2 mg/kg is an alternative when succinylcholine is contraindicated, though onset is 60-90 seconds. Sugammadex 16 mg/kg can immediately reverse rocuronium if the airway cannot be secured.

The trauma patient presents unique challenges: hypovolemia, potential for full stomach, cervical spine injury, and uncertainty about the full extent of injuries. Damage control resuscitation principles apply: permissive hypotension (target MAP of 65 mmHg or 80-90 mmHg in traumatic brain injury), balanced transfusion (1:1:1), and early surgical hemostasis. Ketamine is the induction agent of choice for hemorrhagic shock due to its cardiovascular stability and sympathomimetic effects. In suspected cervical spine injury, manual in-line stabilization is maintained during intubation; video laryngoscopy is preferred to minimize cervical motion. A bougie is routinely used for difficult airways in trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) can provide temporary hemorrhage control in exsanguinating hemorrhage below the diaphragm. The anesthesiologist plays a critical role in resuscitative thoracotomy for penetrating trauma, providing airway management, volume resuscitation, and administering drugs during open cardiac massage.

Anaphylaxis during anesthesia is a life-threatening emergency with an incidence of 1:10,000 to 1:20,000. Neuromuscular blocking agents are the most common trigger (50-60%), followed by latex, antibiotics, and induction agents. Diagnosis is clinical: hypotension, bronchospasm, skin changes (urticaria, flushing, angioedema), and cardiovascular collapse. The severity is graded using the Ring and Messmer classification. Immediate management: stop the suspected trigger, call for help, administer epinephrine (50-100 mcg IV bolus, repeated every 1-2 minutes as needed, or infusion of 0.1-1 mcg/kg/min), secure the airway, administer 100% oxygen, rapid IV crystalloid infusion (1-2 L), and antihistamines (diphenhydramine 50 mg IV, ranitidine 50 mg IV). Steroids (hydrocortisone 200 mg IV) are given to prevent biphasic reactions. Mast cell tryptase levels should be drawn within 1-4 hours. Malignant hyperthermia (MH) is a hypermetabolic crisis triggered by succinylcholine and volatile anesthetics. Susceptibility is due to an inherited mutation in the ryanodine receptor (RYR1). Signs: masseter spasm, generalized rigidity, tachycardia, tachypnea, hypercapnia (early sign), metabolic acidosis, hyperkalemia, and rapidly rising temperature. Treatment: immediately discontinue triggers, hyperventilate with 100% oxygen at high flows, administer dantrolene 2.5 mg/kg IV (repeated until symptoms resolve), cool the patient, treat hyperkalemia (insulin + glucose, calcium, beta-agonist), correct acidosis, and monitor for recurrence. Transfer to ICU for ongoing monitoring.